Skip to main content

KR

SCIENCE

Our Publications​

Filter

AD

The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer’s disease

July 13, 2023
Objectives Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by progressive long-term memory loss…
AD

The role of microRNA-485 in neurodegenerative disease

July 7, 2022
Neurodegenerative diseases (NDDs) are age-related disorders characterized by progressive neurodegeneration and neuronal cell loss in…
AD Biomarker

Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression

December 4, 2021
1. BIORCHESTRA Co., Ltd., 17, Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea 2. Department of Infection…
AD

Innate Immunity and Cell Death in Alzheimer’s Disease

October 20, 2021
The innate immune system plays key roles in controlling Alzheimer's disease (AD), while secreting cytokines…
AD Biomarker

MicroRNAs as a Diagnostic Biomarker in Alzheimer’s Disease: Potential Roles and Characteristics

September 14, 2021
Chang Youn Lee1, Jin Hyeob Ryu1* and Hyun Jeong Cho2* Biorchestra Co. Ltd., Techno 4-ro,…
mRNA Vaccine

Influenza Viruses: Innate Immunity and mRNA Vaccines

August 31, 2021
Front. Immunol., 31 August 2021 Sec. Vaccines and Molecular Therapeutics View Publication
AD Biomarker

miRNAs as Therapeutic Tools in Alzheimer’s Disease

May 28, 2021
1. BIORCHESTRA Co., Ltd., Techno4-ro 17, Daejeon 34013, Korea 2. Department of Biomedical Laboratory Science,…
Diagnosis

Diagnostic and therapeutic biomarkers for Alzheimer’s disease in human‑derived platelets

December 12, 2020
2020 Dec;42(12):1467-1475. doi: 10.1007/s13258-020-01015-6. Epub 2020 Nov 12. View Publication

Filter

AD

The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer’s disease

July 13, 2023
Objectives Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by progressive long-term memory loss…
AD

The role of microRNA-485 in neurodegenerative disease

July 7, 2022
Neurodegenerative diseases (NDDs) are age-related disorders characterized by progressive neurodegeneration and neuronal cell loss in…
AD

Innate Immunity and Cell Death in Alzheimer’s Disease

October 20, 2021
The innate immune system plays key roles in controlling Alzheimer's disease (AD), while secreting cytokines…

Filter

AD Biomarker

Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression

December 4, 2021
1. BIORCHESTRA Co., Ltd., 17, Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea 2. Department of Infection…
AD Biomarker

MicroRNAs as a Diagnostic Biomarker in Alzheimer’s Disease: Potential Roles and Characteristics

September 14, 2021
Chang Youn Lee1, Jin Hyeob Ryu1* and Hyun Jeong Cho2* Biorchestra Co. Ltd., Techno 4-ro,…
AD Biomarker

miRNAs as Therapeutic Tools in Alzheimer’s Disease

May 28, 2021
1. BIORCHESTRA Co., Ltd., Techno4-ro 17, Daejeon 34013, Korea 2. Department of Biomedical Laboratory Science,…

Filter

mRNA Vaccine

Influenza Viruses: Innate Immunity and mRNA Vaccines

August 31, 2021
Front. Immunol., 31 August 2021 Sec. Vaccines and Molecular Therapeutics View Publication

Filter

Diagnosis

Diagnostic and therapeutic biomarkers for Alzheimer’s disease in human‑derived platelets

December 12, 2020
2020 Dec;42(12):1467-1475. doi: 10.1007/s13258-020-01015-6. Epub 2020 Nov 12. View Publication

© 2023 BIORCHESTRA Co., Ltd. All Rights Reserved

KR

Locations

Korea Headquarters

#615 ~ 619, Unit B, 17, Techno 4-ro,
Yuseong-gu, Daejeon,
34013. South Korea

Drug Delivery System
Manufacturing Plant

1, Gukjegwahak 2-ro,
Yuseong-gu, Daejeon,
34000. Korea

U.S. Headquarters

1 Kendall square,
Building 200, Suite 2-103,
Cambridge, MA,
02139, USA

Reagent for BIOMARKER
Analysis Manufacturing Plant

#116/216, 125 Gwahak-ro,
Yuseong-gu, Daejeon, 34141.
Korea

BIORCHESTRA Global

KR

© 2023 BIORCHESTRA Co., Ltd. All Rights Reserved